Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Bullous diffuse cutaneous mastocytosis (BDCM) is a form of diffuse cutaneous mastocytosis (DCM) characterized by generalized erythroderma and severe blistering associated with the accumulation of mast cells in the skin.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for bullous diffuse cutaneous mastocytosis.
5 publications have been identified in PubMed for bullous diffuse cutaneous mastocytosis. Research spans Review / Meta-Analysis (40%), Case Report / Case Series (40%), and Other (20%).
Kaufman LC (2026). [PMID: 41480868](https://pubmed.ncbi.nlm.nih.gov/41480868/). *Pediatr Ann*. [Review / Meta-Analysis]
Bennani K (2026). [PMID: 42226882](https://pubmed.ncbi.nlm.nih.gov/42226882/). *Cureus*. [Case Report / Case Series]
Roux J (2025). [PMID: 39927220](https://pubmed.ncbi.nlm.nih.gov/39927220/). *JAAD Case Rep*. [Case Report / Case Series]
Mendiratta V (2025). [PMID: 41262266](https://pubmed.ncbi.nlm.nih.gov/41262266/). *Indian J Dermatol*. [Other]
Pernea P (2025). [PMID: 40434754](https://pubmed.ncbi.nlm.nih.gov/40434754/). *JAMA Dermatol*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center